AC THERAPEUTICS LIMITED
Get an alert when AC THERAPEUTICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2025-12-26
Overdue
Watchouts
Cash
£41M
+805.3% vs 2023
Net assets
£79M
+99.9% vs 2023
Employees
135
+26.2% vs 2023
Profit before tax
£399K
+126.1% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2025-12-26.
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £83,406,150 | £95,745,709 | |
| Operating profit | -£1,385,723 | £1,059,960 | |
| Profit before tax | -£1,530,534 | £398,892 | |
| Net profit | -£1,598,141 | -£1,142,575 | |
| Cash | £4,485,412 | £40,606,160 | |
| Total assets less current liabilities | £39,585,603 | £79,363,347 | |
| Net assets | £39,565,603 | £79,098,288 | |
| Equity | £39,565,603 | £79,098,288 | |
| Average employees | 107 | 135 | |
| Wages | £9,849,179 | £11,349,800 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -1.7% | 1.1% | |
| Net margin | -1.9% | -1.2% | |
| Return on capital employed | -3.5% | 1.3% | |
| Current ratio | 2.57x | 3.51x | |
| Interest cover | -9.54x | 4.01x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- PKF Littlejohn LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Bearing in mind the new investment into the Group in the year, the cash flow forecast and the strength of the Group and Company's balance sheet, the Directors, therefore, have a reasonable expectation that the Group and Company has adequate resources to continue in operational existence and have consequently prepared the accounts on a going concern basis.”
Group structure
- AC THERAPEUTICS LIMITED · parent
- ASC Regenity Limited 42%
- ASC Skin Therapeutics Limited 74.4%
- ASC Clinics Limited 100%
- Augustinus Bader Foundation 100%
- ASC Regenity Inc 42%
- ASC Innovation GmbH 42%
- ASC Regenity (Shanghai) Trading Co., Ltd 42%
- ASC Regenity Pte Ltd 42%
- AB JV Co Ltd 21%
- Regenity (Shanghai) Cosmetics Co. Ltd 42%
- Bader Chopra LLC 21%
Significant events
- “Revenue growth driven by expansion into new overseas markets; Introduction of new product lines; Further development and enhancement of the online platform to strengthen market leadership; Establishment of a new joint venture in China.”
- “The Group established a wholly owned entity in Singapore to support expansion efforts.”
- “A HSBC UK credit facility was obtained during the year, providing additional liquidity and financial flexibility.”
- “A gain of £41.5 million arose from the disposal of a non-controlling share of the Company's fixed asset investment.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ROSIER, Charles Antoine Monique Chantal | Director | 2017-04-13 | Nov 1973 | French |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BADER, Augustinus, Prof | Director | 2016-12-13 | 2025-09-03 |
| VEYRAT, Jacques Francis | Director | 2025-09-03 | 2026-02-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Charles Rosier | Individual | Shares 25–50%, Voting 25–50% | 2017-04-13 | Active |
| 3ys Pte Ltd | Corporate entity | Shares 25–50%, Voting 25–50%, Appoints directors | 2016-12-13 | Ceased 2016-12-13 |
| Prof Augustinus Bader | Individual | Shares 25–50%, Voting 25–50% | 2016-12-13 | Active |
Filing timeline
Last 20 of 41 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-12-29 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-16 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-09 | AA | accounts | Accounts with accounts type group | |
| 2025-12-29 | SH20 | capital | Legacy | |
| 2025-12-29 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-12-29 | CAP-SS | insolvency | Legacy | |
| 2025-12-29 | RESOLUTIONS | resolution | Resolution | |
| 2025-10-27 | CH01 | officers | Change person director company with change date | |
| 2025-09-12 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-31 | AA | accounts | Accounts with accounts type group | |
| 2024-08-14 | DISS40 | gazette | Gazette filings brought up to date | |
| 2024-08-13 | GAZ1 | gazette | Gazette notice compulsory | |
| 2024-08-07 | AA | accounts | Accounts with accounts type group | |
| 2024-02-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-12 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2024-02-02 | CH01 | officers | Change person director company with change date | |
| 2023-08-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-03-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-09 | AA | accounts | Accounts with accounts type group |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+14.8%
£83,406,150 £95,745,709
-
Cash
+805.3%
£4,485,412 £40,606,160
-
Net assets
+99.9%
£39,565,603 £79,098,288
-
Employees
+26.2%
107 135
-
Operating profit
+176.5%
-£1,385,723 £1,059,960
-
Profit before tax
+126.1%
-£1,530,534 £398,892
-
Wages
+15.2%
£9,849,179 £11,349,800
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers